Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker AnalysesJung Min Lee, Elise C. Kohn, John L. Hays et al.|JNCI Journal of the National Cancer Institute|2014Cited by 184
Workshop on imaging science development for cancer prevention and preemptionGary J. Kelloff, Randall W. Burt, Robert J. Nordstrom et al.|Cancer Biomarkers|2006Cited by 22